Publications by authors named "Kevin Carl"

Claim this Profile
A
A Call To Action: Developing an Agile Global Regulatory Affairs Workforce for the Future.
Lina AlJuburi, Nicole Mahoney, Eddie Reilly, Amy Bertha, David C Isom, Kevin Carl, Carlos O Garner

Ther Innov Regul Sci· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Accelerating adoption of new approach methodologies in regulatory decision making: an industry perspective.
Andrew S Robertson, Nahid Latif, Imein Bousnina, Donna Boyce, Kevin Carl, Carlos O Garner

Nat Rev Drug Discov· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Deprescribing anticholinergic medication in the community mental health setting: A quality improvement initiative.
Jessica M Gannon, Ana Lupu, Jaspreet Brar, Myranda Brandt, Susanna Zawacki, Kevin Carl

Res Social Adm Pharm· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and regulatory strategies for drug and diagnostic co-development.
Lois M Hinman, Kevin M Carl, Brian B Spear, Ronald A Salerno, Robert L Becker

Pharmacogenomics· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Voluntary exploratory data submissions to the US FDA and the EMA: experience and impact.
Federico M Goodsaid, Shashi Amur, Jiri Aubrecht, Michael E Burczynski, Kevin Carl

Nat Rev Drug Discov· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Towards consensus practices to qualify safety biomarkers for use in early drug development.
Frank D Sistare, Frank Dieterle, Sean Troth, Daniel J Holder, David Gerhold, Kevin Carl

Nat Biotechnol· May 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Renal biomarker qualification submission: a dialog between the FDA-EMEA and Predictive Safety Testing Consortium.
Frank Dieterle, Frank Sistare, Federico Goodsaid, Marisa Papaluca, Josef S Ozer, Kevin Carl

Nat Biotechnol· May 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Urinary clusterin, cystatin C, beta2-microglobulin and total protein as markers to detect drug-induced kidney injury.
Frank Dieterle, Elias Perentes, André Cordier, Daniel R Roth, Pablo Verdes, Kevin Carl

Nat Biotechnol· May 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis